Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02995694Phase 3Completed
Phase 3, randomised, double-blind trial of estradiol topical in atrophic vaginitis (3 arms), sponsored by Alvogen. Primary endpoint: Vaginal Cytology at Day 8. Started Mar 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02995694.